{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:23Z","timestamp":1753890623176,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prospective data registration is the basis of clinical oncological research. Commonly, case documentation is restricted to studies investigating a defined hypothesis. Only few institutions prospectively register all oncological patients with a reliable, sustainable and continuous follow-up infrastructure. The Department of Urology of the Heidelberg University Hospital started its prospective tumor data base in 1992. Since then, the clinical course of all oncological in-patients is continuously registered within a life-long follow-up (success rate: 93%). Associated tumor tissue is stored in the Heidelberg Biobank. In 2005, the transfer of this invaluable registry from the initial InterSystemsCache\u00ae\/KRAZTUR system to a modern data warehouse was initiated. However, the transfer of existing data into a new environment proved to be technically challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To migrate the existing data into a modern data warehouse (DATA 5.0) while maintaining data extraction functions. Additional requirements included FHIR connectivity, big data analyses and AI applications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Together with SAP SE, DATA 5.0 was developed. Based on SAP HANA\u00ae (High Performance Analytic Appliance) it allows data registration and analysis with third party analytical tools. The project was supported by members of the SAP SE executive board and funded by the Dietmar Hopp Foundation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data Acquisition, Translation &amp;amp; Analysis 5.0 (DATA 5.0), a web-based tool for data registration, preservation and analysis of treatment and follow-up data, was developed to proof-of-concept stage. DATA 5.0 was then implemented into clinical practice replacing the previous system. As of today, 15,345 oncological patients and 6.7 Mio. data points are registered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prospective long-term data was successfully migrated into DATA 5.0, allowing data preservation, flexibility and capabilities for future data sources. DATA 5.0, together with associated tumor tissue, is a lighthouse platform for oncological research, with capability for third party analytical tools, big data analysis and AI applications including training of digital twin models.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdgth.2025.1530321","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T23:37:01Z","timestamp":1743118621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["DATA 5.0\u2014Data Acquisition, Translation &amp; Analysis\u2014a prospective urooncological data warehouse for the 21st century"],"prefix":"10.3389","volume":"7","author":[{"given":"Viktoria","family":"Sch\u00fctz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"B\u00f6ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Treber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Brobeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Duensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Duensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"G\u00f6rtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.urolonc.2012.01.016","article-title":"Two decades\u2019 experience with a prospective biobank for urologic oncology: research, clinical care, and the patients\u2019 view","volume":"31","author":"Huber","year":"2013","journal-title":"Urol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","article-title":"Overview of the surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance","volume":"36","author":"Park","year":"2012","journal-title":"Curr Probl Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e032707","DOI":"10.1136\/bmjopen-2019-032707","article-title":"Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile","volume":"9","author":"Janet","year":"2019","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/2042098611435911","article-title":"Recent advances in the utility and use of the general practice research database as an example of a UK primary care data resource","volume":"3","author":"Williams","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"B5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00103-015-2301-8","article-title":"BBMRI-ERIC: the novel gateway to biobanks","volume":"59","author":"Mayrhofer","year":"2016","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"first-page":"374","volume-title":"The Learning Healthcare System: Workshop Summary","year":"2007","key":"B6"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e12536","DOI":"10.1200\/jco.2010.28.15_suppl.e12536","article-title":"French brain tumor data bank (FBTDB): main results on 23,648 cases","volume":"28","author":"Rigau","year":"2010","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4048\/jbc.2010.13.1.96","article-title":"Five-years of breast cancer management in a new hospital: analysis using clinical data warehouse","volume":"13","author":"Kang","year":"2010","journal-title":"J Breast Cancer"},{"key":"B9","first-page":"281","article-title":"The NCIC-manitoba breast tumor bank: a resource for applied cancer research","volume":"155","author":"Watson","year":"1996","journal-title":"CMAJ"},{"year":"2023","key":"B10","article-title":"cancercentrum R"},{"key":"B11","first-page":"423","article-title":"Data warehousing as a basis for web-based documentation of data mining and analysis","volume":"68","author":"Karlsson","year":"1999","journal-title":"Stud Health Technol Inform"},{"year":"","key":"B12","article-title":"ACS\/American College of Surgeons. (1996-2025)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-022-00502-0","article-title":"Big data in basic and translational cancer research","volume":"22","author":"Jiang","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/gcc.23135","article-title":"Real-world data for precision cancer medicine-a European perspective","volume":"62","author":"Christopoulos","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"ncomms11845","DOI":"10.1038\/ncomms11845","article-title":"Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity","volume":"7","author":"Hoefflin","year":"2016","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/jcm11010202","article-title":"Evolution of salvage radical prostatectomy from open to robotic and further to retzius sparing surgery","volume":"11","author":"Schuetz","year":"2022","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.3390\/cancers15245715","article-title":"Long-term survival of patients with stage T1N0M1 renal cell carcinoma","volume":"15","author":"Sch\u00fctz","year":"2023","journal-title":"Cancers"},{"year":"2023","key":"B18","article-title":"NCT Gewebebank"},{"key":"B19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00428-010-0998-1","article-title":"Quality management and accreditation of research tissue banks: experience of the national center for tumor diseases (NCT) Heidelberg","volume":"457","author":"Herpel","year":"2010","journal-title":"Virchows Arch"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/S0140-6736(07)60924-6","article-title":"UK biobank: bank on it","volume":"369","author":"Palmer","year":"2007","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000104451","article-title":"Biobanking for interdisciplinary clinical research","volume":"74","author":"Riegman","year":"2007","journal-title":"Pathobiology"},{"key":"B22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/978-3-642-95397-2_62","article-title":"Das dokumentations-, kommunikations- und organisations-system des tumorzentrums Heidelberg\/mannheim mit KRAZTUR","volume-title":"Nachsorge und Krankheitsverlaufsanalyse","author":"Ellsaesser","year":"1981"},{"key":"B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0038-1635311","article-title":"KRAZTUR \u2014 a generator for medical documentation and information systems","volume":"20","author":"Ells\u00e4sser","year":"1981","journal-title":"Methods Inf Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-3591-1-6","article-title":"The ethics of health sector databases","volume":"1","author":"Snaedal","year":"2002","journal-title":"eHealth Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e27743","DOI":"10.2196\/27743","article-title":"A platform and multisided market for translational, software-defined medical procedures in the operating room (OP 4.1): proof-of-concept study","volume":"10","author":"G\u00f6rtz","year":"2022","journal-title":"JMIR Med Inform"},{"year":"2023","key":"B26","article-title":"HL7 FHIR Release 5"},{"year":"2016","key":"B27","article-title":"Wikipedia HL7"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.1038\/s41598-018-25544-z","article-title":"Genomic features of renal cell carcinoma with venous tumor thrombus","volume":"8","author":"Warsow","year":"2018","journal-title":"Sci Rep"},{"key":"B29","first-page":"1","article-title":"Data is the new oil","author":"Humby","year":"2006"},{"key":"B30","article-title":"10 ideas changing the world right now\u2014biobanks","volume":"173","author":"Park","year":"2009","journal-title":"Time Magazine"},{"article-title":"Guide to Biobanks in Sweden\u2014Access to Samples for Research and Clinical trials (2019)","year":"","author":"Sverige","key":"B31"},{"year":"","key":"B32","article-title":"BBMRI-ERIC. (2020)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1176935117694349","DOI":"10.1177\/1176935117694349","article-title":"Roadmap to a comprehensive clinical data warehouse for precision medicine applications in oncology","volume":"16","author":"Foran","year":"2017","journal-title":"Cancer Inform"},{"article-title":"BioMaterialBank Heidelberg (BMBH)","year":"2023","author":"Heidelberg","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.ctarc.2020.100230","article-title":"Detection of AR-V7 in primary prostate cancer","volume":"28","author":"Kaczorowski","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8.e11","DOI":"10.1016\/j.urolonc.2021.06.024","article-title":"Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer","volume":"40","author":"Nientiedt","year":"2022","journal-title":"Urol Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"161.e119","DOI":"10.1016\/j.urolonc.2017.11.001","article-title":"Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy","volume":"36","author":"Chen","year":"2018","journal-title":"Urol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2200182","DOI":"10.1200\/cci.22.00182","article-title":"Developing a data and analytics platform to enable a breast cancer learning health system at a regional cancer center","volume":"7","author":"Petch","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"B40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1200\/jco.23.02399","article-title":"Real-world database studies in oncology: a call for standards","volume":"42","author":"Ramsey","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1530321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T23:37:25Z","timestamp":1743118645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1530321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":40,"alternative-id":["10.3389\/fdgth.2025.1530321"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2025.1530321","relation":{},"ISSN":["2673-253X"],"issn-type":[{"type":"electronic","value":"2673-253X"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"article-number":"1530321"}}